|
|
||||||||
RECEPTORS AND SIGNAL TRANSDUCTION
1Department of Physiology and Cell Biology and 2Cytometry Center, University of Nevada, and 3Sierra Cytometry, Reno, Nevada
Submitted 31 March 2006 ; accepted in final form 16 August 2006
| ABSTRACT |
|---|
|
|
|---|
Kit; substance P; neurokinin-1 receptor; flow cytometry; RT-PCR
The functions of ICC are performed by distinct classes located in discrete regions of the gastrointestinal (GI) tunica muscularis. For example, in the small intestine pacemaker activity driving electrical slow waves is generated and propagated by multipolar ICC that form a two-dimensional network in the myenteric region (ICC-MY) (18, 22, 43, 49, 50, 52), whereas inhibitory and excitatory neurotransmission to smooth muscle cells is mediated by elongated ICC (intramuscular ICC, ICC-IM) within the circular muscle layer that form close synaptic contacts with varicose processes of enteric motor neurons (4, 15, 19, 47, 48, 51, 53). In the small bowel ICC-IM are often referred to as ICC-DMP as these cells are concentrated in the region of the deep muscular plexus (19, 48, 53). In humans, ICC-DMP and ICC-IM may coexist as separate classes (47), and it is unclear whether additional functions are provided by these cells. Mechanoreception is accomplished by ICC-IM in the stomach (54), and it is possible that these cells also contribute to afferent neural signaling in the stomach and rectum (see Refs. 6, 9, 10).
The cellular and molecular mechanisms of the functions of ICC are not fully understood. Molecular analysis of ICC is difficult because of the scarcity and widespread distribution of these cells in the tunica muscularis. Therefore, gene expression underlying specific ICC functions has either been inferred from physiological, pharmacological, and immunohistochemistry experiments or studied on a smaller scale, e.g., in a few isolated cells. Using an array of experimental approaches, we have proposed (23, 36, 52) a comprehensive model of electrical pacemaking by small intestinal ICC-MY that incorporates the dependence of slow wave activity on mitochondrial function and intracellular Ca2+ signaling. However, some aspects of this model have been challenged (1, 15, 37, 42, 44, 56), and the molecular identity of key ionic conductances associated with electrical pacemaking remains unclear. The molecular basis for the mediation of motor neurotransmission by ICC-IM and ICC-DMP is likely to involve expression of proteins that participate in the binding and transduction of neurotransmitters. For example, previous studies have shown that ICC express a variety of receptors, including peptide receptors, such as neurokinin (19, 25, 32, 46), somatostatin (41) and VIP receptors (7), M2 and M3 muscarinic receptors (7), and nucleotide receptors (5). Expression of intracellular signaling intermediates such as protein kinases (30, 40) and cGMP (38, 55) is also consistent with a role for ICC-IM in mediating neuroeffector functions. Moreover, ICC-IM may also amplify the efferent neuronal signals by producing intercellular signaling molecules, such as nitric oxide (33, 45), CO (27), and prostaglandins (31). Despite the division of labor between ICC-MY and ICC-IM (or ICC-DMP), certain receptors found in cells that mediate neurotransmission can also be found in pacemaker ICC that do not appear to be direct targets of neuroeffector signaling (7, 25).
Understanding how ICC accomplish specialized functions may be aided by large-scale analysis of gene expression. ICC are only a minor component of GI muscles, so general molecular analyses of the tunica muscularis are obscured by the expression patterns of other cell types. We recently reported techniques to identify murine ICC in cell suspensions (29). This technique is based on the detection of Kit, which is the receptor for stem cell factor and is an established immunohistological marker for ICC. Our approach permits enumeration of ICC by flow cytometry (FCM) from any part of the GI tract (28) and isolation of cells in great numbers at very high degree of purity by fluorescence-activated cell sorting (FACS) (16, 29). It is, however, incapable of distinguishing between ICC classes from the same tissue. Recent studies have identified neurokinin-1 receptors (NK1R) on ICC-DMP and some myenteric neurons, but not on ICC-MY (19, 46). Thus simultaneous identification of Kit- and NK1R-expressing cells may allow discrimination of ICC-DMP and ICC-MY from the same tissues. In the present study we have utilized this concept to develop approaches to selectively isolate functional ICC classes from murine and human small intestines. We have also demonstrated that, with these labels, it may be feasible to obtain sufficient cells to perform large-scale genomic studies on functional classes of ICC.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Human tissues. Human jejunal segments were obtained as surgical waste during gastric bypass surgeries for morbid obesity. The protocol was approved by the University of Nevada, Reno and the University of California, Davis Human Subjects Research Committees. The studies were conducted according to Declaration of Helsinki principles. Tissue strips 15 mm in length were cut parallel to the circular muscle fibers with a knife consisting of a pair of parallel scalpel blades set 1.5 mm apart. The tunica mucosa was removed, and the circular muscle layer and the myenteric region were separated by sharp dissection.
Vital labeling with fluorescent substance P. NK1R-expressing cells in murine and human tissues were identified either by immunohistochemistry for NK1R or by receptor-mediated internalization of fluorescent substance P (SP) (19, 25). Murine tunica muscularis tissues were exposed to SP or Oregon Green 488-SP (OG488-SP, 1 µM; Molecular Probes, Eugene, OR), initially at 4°C for 1 h to allow the agonist to bind to cell surface receptors, followed by incubation at 37°C for 20 min to facilitate the internalization of the agonist-receptor complexes (19). Vital labeling of human tissues was performed similarly except that the jejunal tissue strips were incubated at 4°C for 4 h and at 37°C for 30 min. In some of these experiments, SP conjugated with Alexa Fluor 488 (AF488; Molecular Probes) was used instead of OG488-SP.
Immunohistochemistry. After vital labeling with OG488-SP, murine and human tissues were stretched to 110% of their resting length, fixed with 4% paraformaldehyde-saline (pH 7.40; 10 min at room temperature), and permeabilized with 0.3% (vol/vol) Triton X-100 (Sigma, St. Louis, MO; 1 h at 4°C). Nonspecific antibody binding was reduced by incubating the tissues in 1% (wt/vol) bovine serum albumin (BSA; Sigma; 1 h at room temperature). ICC in the murine and human tissues were labeled with monoclonal anti-Kit antibodies (anti-mouse Kit: clone 2B8, eBioscience, San Diego, CA; anti-human Kit: clone YB5.B8, BD Pharmingen, San Diego, CA). The primary antibodies were applied at 5 µg/ml for 48 h at 4°C and visualized with Alexa Fluor 594-conjugated secondary antibodies (goat anti-rat IgG or chicken anti-mouse IgG; Molecular Probes; 10 µg/ml, 1 h at room temperature). Specificity was verified by omitting either the primary or the secondary antibodies. Whole mounts were examined with a Zeiss LSM 510 META confocal microscope (Carl Zeiss Microimaging, Thornwood, NY).
For examination of NK1R internalization, whole mounts (5 x 10 mm) were pinned to Sylgard elastomer panels (1 x 10 x 15 mm) at 110% of resting length and width. Tissues were immersed in an organ bath and allowed to equilibrate in KRB (97% O2-3% CO2) at 37.5 ± 0.5°C for 60 min before experiments were initiated. Experiments were performed in N
-nitro-L-arginine (0.1 mM) and monensin (5 µM). After stimulation with SP (1 µM; 60 min at 4°C, followed by 20 min at 37°C), the muscles were fixed with Zamboni fixative for 1 h at room temperature, followed by wash with 0.01 M phosphate-buffered saline (PBS, pH 7.4) with 0.3% Triton X-100 overnight with several changes of the solution. Control tissues were not exposed to SP before fixation. Nonspecific antibody binding was reduced by incubation of the tissues in BSA (1% in PBS; Sigma) for 1 h at room temperature. Tissues were incubated with antibody to NK1R (rabbit polyclonal antiserum, 1:2,000; Sigma S8305) diluted with PBS containing Triton X-100 (0.3%) for 48 h at 4°C.
Manual harvesting of ICC-DMP/IM identified by receptor-mediated uptake of fluorescent SP. NK1R-expressing cells in murine and human tissues were labeled by receptor-mediated internalization of OG488-SP and AF488-SP, respectively. Murine jejunum and ileum tunica muscularis tissues were equilibrated with cold nominally Ca2+- and Mg2+-free Hanks' solution (see Solutions), transferred into collagenase-containing enzyme solution (see Solutions), and incubated, without stirring, at 37°C for 30 min. Tissue strips prepared from human jejunal circular muscles were incubated in enzyme solution overnight at 4°C and then at 37°C for 2025 min. After three washes, the murine and human tissues were triturated through a series of three blunt pipettes of decreasing tip diameter. The resultant cell suspensions were counterstained with monoclonal antibodies against the common leukocyte marker CD45 tagged with R-phycoerythrin (PE)-cyanine 5 (PC) tandem conjugates (to identify macrophages and dendritic cells that may nonspecifically take up the fluorescent SP; see details under FCM and FACS below), washed, sedimented by centrifugation (300 g; 5 min), resuspended in 1 ml of Ca2+- and Mg2+-free Hanks' solution, and examined under a Nikon E600FN fluorescence microscope equipped with water-immersion differential interference contrast optics and near-infrared diascopic illumination (Nikon Instruments, Melville, NY). Epifluorescent imaging was performed with a TILL Photonics (Gräfelfing, Germany) system consisting of a Polychrome IV monochromator, an Imago QE camera, and TILLvisION 4.1 software. For manual harvesting of labeled ICC, freshly dispersed cells were placed in glass-bottom dishes on a Nikon Diaphot 2 inverted microscope equipped with fluorescence and phase-contrast optics. Cells with ICC-DMP/IM-like morphology and green fluorescence were sucked into large-diameter, fire-polished micropipettes made from borosilicate capillaries and mounted in a micromanipulator (7). Fifty to eighty cells were pooled for each RT-PCR experiment.
FCM and FACS.
ICC in murine jejunum and ileum tunica muscularis tissues were labeled vitally by incubating with R-PE-conjugated rat monoclonal anti-mouse Kit antibody (clone ACK2, 1 µg/ml KRB; eBioscience) at 4°C for 3 h. NK1R-expressing cells were labeled by receptor-mediated internalization of OG488-SP as described above. After equilibrating with cold nominally Ca2+- and Mg2+-free Hanks' solution (see Solutions), the tissues were transferred into collagenase-containing enzyme solution (see Solutions) and incubated, without stirring, at 37°C for 30 min. After three washes, the tissues were triturated through a series of three blunt pipettes of decreasing tip diameter. The resultant cell suspensions were sedimented by centrifugation (300 g; 5 min), resuspended in 1 ml of Ca2+- and Mg2+-free Hanks' solution containing 5% FBS (GIBCO Invitrogen, Grand Island, NY), and filtered through a polyester filter with 30-µm mesh size (Miltenyi Biotec, Auburn, CA) to obtain single-cell suspensions. Labeling of ICC in these suspensions was reinforced with 0.2 µg of PE-ACK2 (eBioscience). In some experiments, PE-ACK2 was replaced with PE-2B8 (0.5 µg), which reacts with a different extracellular epitope of Kit but recognizes the same complement of Kit+ cells (unpublished observation). Macrophages and dendritic cells that may take up fluorescent labels nonspecifically and mast cells that also express Kit but are strongly CD45 immunopositive were identified with antibodies labeled with PC5 tandem conjugates of rat monoclonal (IgG2b) anti-mouse F4/80 (clone: CI:A3-1, 0.5 µg; CALTAG, Burlingame, CA), rat monoclonal (IgG2b) anti-mouse CD11b (clone M1/70.15, 0.5 µg; CALTAG), and rat monoclonal anti-mouse CD45 (Ly-5 or leukocyte common antigen; clone 30-F11; 0.2 µg; eBioscience) (16, 29). Fibroblasts and endothelial cells that may also contaminate sorted ICC populations were labeled with biotin-anti-CD34 (clone RAM34, 0.5 µg; BD Pharmingen). The cells were incubated with the above antibodies for 30 min at 4°C and then washed, centrifuged (300 g, 5 min), reacted with PC5-streptavidin (0.025 µg; eBioscience), and washed as above. Control cell suspensions were only labeled with either OG488-SP or PE-anti-Kit or the PC5-conjugated antibodies. Flow cytometry was performed with a Beckman Coulter (Fullerton, CA) XL/MCL flow cytometer equipped with an Ar ion laser (excitation wavelength 488 nm), a photodiode to measure light scattered at low forward angles (forward scatter), and photomultiplier tubes (PMT) to measure orthogonally scattered light (side scatter) plus four wavelengths of fluorescence. The optical filters were configured to measure fluorescence at 525 [used for the detection of OG488-SP; emission maximum (Em) 524 nm], 575 (used for the detection of PE-anti-Kit antibodies; Em 575 nm), 675 (used for PC5-labeled antibodies; Em 667 nm) (4042), and >740 (unused) nm. Cells were detected by triggering on forward scatter, and data files of
20,000 events were collected by using the Coulter System II acquisition software. Listmode data files were analyzed with FlowJo (Tree Star, Ashland, OR) software. FACS was performed on a Beckman Coulter EPICS Elite ESP sorter (16, 29) equipped with a flow cell with a 100-µm orifice and optical filters to measure 525-, 575-, 610-, and 670-nm emissions. The PMT voltages were set to match the measurements determined on the analytical instrument. Cells were illuminated in the quartz cuvette with a laser spot measuring 8 µm x 151 µm (height x width). Sheath pressure was 12 psi. Proper instrument operation was verified before each experiment by analyzing standard reference beads. Initial enrichment of all Kit+ ICC (ICC-MY + ICC-DMP) was performed by using a three-drop sort mode ("Recover1"). For final purification of ICC-MY and ICC-DMP the enriched cells were reanalyzed and sorted with a one-drop sort mode that discards all events that may represent cell doublets ("Purity1").
Analysis of gene expression by qualitative RT-PCR. Gene expression studies were performed with established techniques (28, 29). Briefly, total RNA was prepared from the isolated cells with TRIzol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions with minor modifications. RNA was purified with the Absolutely RNA Nanoprep Kit (Stratagene, La Jolla, CA) and reverse transcribed with SuperScript II (Invitrogen). The resultant cDNA was purified with the MinElute PCR purification kit (Qiagen, Valencia, CA) and amplified with specific primers (MWG Biotech, High Point, NC, and Qiagen) (Table 1) by PCR, using the following amplification profile: 95°C for 10 min to activate the AmpliTaq polymerase (Applied Biosystems, Foster City, CA) and then 35 cycles at 94°C for 30 s, 55°C for 30 s, and 72°C for 1 min, followed by an extension step at 72°C for 7 min. The amplified products (10 µl) were separated by electrophoresis on a 2% agarose-1x Tris, acetic acid, EDTA gel, and the DNA bands were visualized by ethidium bromide staining. The specificity of the primers was tested with the Basic Local Alignment Search Tool (http://www.ncbi.nlm.nih.gov/BLAST/) and by sequencing the PCR products. We tested for genomic DNA contamination by PCR using cytoglobin (AJ315163 [GenBank] ) primers that span an intron (sense nt 268289; antisense nt 497519). Nonspecific amplification was determined by omitting the template from the PCR (16, 28, 29).
|
Solutions. Concentrations of solutions (in mmol/l except as noted) are KRB: 120.35 NaCl, 5.9 KCl, 2.5 CaCl2, 1.2 MgCl2, 15.5 NaHCO3, 1.2 NaH2PO4, 11.5 glucose, pH 7.37.4 when bubbled with 97% O2 and 3% CO2; Ca2+- and Mg2+-free Hanks' solution: 125 NaCl, 5.36 KCl, 15.5 NaHCO3, 0.336 Na2HPO4, 0.44 KH2PO4, 10 glucose, 2.9 sucrose, and 11 HEPES adjusted to pH 7.2 with NaOH; and enzyme solution: collagenase (1.3 mg/ml, Worthington type II; Worthington Biochemical, Freehold, NJ), BSA (2 mg/ml), trypsin inhibitor (2 mg/ml), and ATP (0.27 mg/ml) (all from Sigma) in Ca2+- and Mg2+-free Hanks' solution.
| RESULTS |
|---|
|
|
|---|
|
|
We next attempted to identify ICC-DMP/IM in cell suspensions prepared from murine tunica muscularis (n = 8; Fig. 3, AC) and human circular muscle strips (n = 3; Fig. 3, DF). Cells with functional NK1R were labeled in whole mount preparations by receptor-mediated internalization of OG488-SP (murine tissues) or AF488-SP (human tissues). In both preparations, cells with SP-associated fluorescence were slender and bipolar (presumed ICC-DMP/IM; Fig. 3, A and D) or oval shaped (presumed to be neurons; Fig. 3, B and E). Neither type of cell was labeled with antibodies against the common leukocyte marker CD45 (not shown). We harvested 5080 OG488-SP-positive cells from each suspension and analyzed them for the expression of cell-specific markers by RT-PCR. Kit mRNA was detected in each cell population examined, but we did not detect mRNAs for the neuronal marker protein gene product 9.5, the macrophage/dendritic cell marker CD68, or the smooth muscle marker myosin heavy chain 11 (Fig. 3, C and F). These tests identify the OG488-SP-positive cells as ICC-DMP/IM.
|
3-and
3-subunits, and both type I and type II cGMP-dependent protein kinase. Importantly, we did not detect mRNA encoding for either L- or T-type Ca2+ channels in ICC-DMP populations despite abundant expression in whole muscles.
|
12,000 ICC-DMP and
55,000 ICC-MY per small intestine. The sorted populations had excellent purity, which was verified by FCM analysis (Fig. 5, E and F) and/or RT-PCR (Fig. 5G). For example, the cells analyzed in the experiment shown in Fig. 5G only expressed mRNA for Kit (ICC-MY) or Kit and NK1R (ICC-DMP) but not markers for smooth muscle cells, glia, neurons, mast cells, macrophages/dendritic cells, and fibroblasts/endothelial cells.
|
| DISCUSSION |
|---|
|
|
|---|
Our approach was based on previous findings that ICC-DMP and a subpopulation of myenteric neurons express NK1R, whereas expression of this receptor was not detected on ICC-MY (19, 46). NK1R is the preferred receptor for the excitatory enteric neurotransmitter SP, and SP-containing enteric neurons have been shown to functionally and preferentially innervate ICC-DMP in both mice and guinea pigs (19, 25, 32, 46). Thus it is likely that a portion of the noncholinergic excitatory response to SP is mediated via ICC-DMP. Exposure of murine small intestinal muscles to exogenous SP caused NK1R internalization in myenteric neurons and ICC-DMP (19). In contrast, SP exposure did not reveal NK1R-like immunoreactivity in ICC-MY. Here we have used receptor internalization to load ICC-DMP (and possibly ICC-IM in the human) with a fluorescent tag, and among Kit-positive cells we could detect internalization of fluorescent SP only in ICC-DMP and not in ICC-MY. Identical results were obtained for jejunal cells (Fig. 1). In both parts of the small intestine, myenteric neurons, intramural nerve fibers, and, very rarely, smooth muscle cells also internalized the fluorescent SP but they could be easily distinguished from ICC by their lack of Kit immunoreactivity. The use of receptor-mediated uptake of fluorescent SP coupled with Kit immunolabeling permitted the selective and quantitative detection of ICC-DMP/IM.
Little is known about ICC in human GI muscles, and most of the functional conclusions about the role of ICC have been deduced from studies of animal models. Thus we attempted to extend the validity and usefulness of our experiments to develop techniques that might make it possible in the future to assess the molecular apparatus of human ICC. SP is also a major excitatory neurotransmitter in the human gut (12). Cells with ICC-like morphology have been shown to express NK1R or bind radioactive SP throughout the human GI tract (24, 26, 39). In circular muscles of the human jejunum we observed internalization of fluorescent SP in ICC-DMP/IM and nerve fibers but not in ICC-MY or smooth muscle cells (Fig. 2). At the present time we are unable to report that uptake of SP was exclusively by ICC-DMP, and we do not yet have a good means to separate ICC-IM and ICC-DMP from human muscles. More work will be necessary to develop a technique to label these cells specifically. Another problem encountered with human cells was incomplete labeling of all ICC-DMP/IM. This may have been due to technical problems, such as poor penetration of the labeled SP, or nonuniform expression of NK1R on ICC-DMP/IM. Thus, while it is possible to achieve selective identification of some of the ICC-DMP/IM from human jejunum, these findings suggest that the technique we have developed for separation of murine ICC is unsuitable, under present experimental conditions, for the selective detection and harvesting of human ICC-MY. Thus we concentrated molecular studies and further development and refinement of selection techniques on studies of murine cells.
As a first step toward selective harvesting of small intestinal ICC for molecular analyses, we collected murine ICC-DMP and human ICC-DMP/IM from cell suspension with the aid of fluorescent microscopy (Fig. 3). Cells were selected on the basis of their internalization of fluorescent SP and elongated or bipolar morphology. Without exception, each batch of 5080 cells was found to express mRNA for the ICC marker Kit but not for the neuronal marker protein gene product 9.5 (Uchl1), the smooth muscle marker myosin heavy chain (Myh11), or the macrophage/dendritic cell marker CD68, indicating that receptor-mediated uptake of fluorescent SP combined with microscopic assessment of cell morphology is sufficient for the selective detection of mouse ICC-DMP and human ICC-DMP/IM in suspension.
In three independently harvested populations of murine ICC-DMP we examined mRNA encoding for neurotransmitter receptors, intracellular signaling intermediates, and Ca2+ channels considered important for normal GI motility (Fig. 4). Consistent with previous reports (7, 19, 25, 32, 46), we detected expression of M2 and M3 muscarinic receptors (Chrm2 and Chrm3) and NK1R (Tacr1), i.e., receptors for enteric excitatory neurotransmitters in the GI tract. We did not, however, detect mRNA for tachykinin-3 receptors, as previously reported for ICC-IM and ICC-MY harvested from dispersed murine fundic and small intestinal muscles, respectively (7). Previous reports have also identified ICC as targets of inhibitory neuromuscular neurotransmission (53). For example, ICC have been reported to express VIP receptor 2 (7) and cGMP (38, 55), a second messenger synthesized in response to binding of nitric oxide to soluble guanylyl cyclase (21). In the present study we detected mRNA for purinergic P2Y1 and pyrimidinergic P2Y4 receptors in isolated ICC-DMP. To our knowledge, this is the first report of P2Y receptor isoforms in ICC, and the functional significance of these findings may be linked to the initial component of the inhibitory junction potentials in GI muscles. In contrast with results of Epperson et al. (7), we could detect only VIP receptor 2, but not VIP receptor 1, in either ICC-DMP or whole small intestinal muscles. The reason for this discrepancy is unclear, but it is important to mention that murine colonic muscles also appear to express type 2, rather than type 1, VIP receptors (2). Consistent with a role for ICC in nitrergic signaling (53), we detected mRNA encoding isoforms of soluble guanylyl cyclase-1 (Gucy1a3, Gucy1b3) and cGMP-dependent protein kinase (Prkg1, Prkg2) in isolated ICC-DMP. In contrast, and despite abundant expression in whole muscles, we found no evidence of expression by ICC-DMP of either T-type Ca2+ channels (Cacna1g, Cacna1h, and Cacna1i subunits), which play a role in electrical pacemaking by ICC-MY (20), or L-type Ca2+ channels (Cacna1c and Cacna1d subunits), which are important for smooth muscle contractile activity. Thus our observations are consistent with a role for ICC-DMP as mediators of excitatory and inhibitory neuromuscular neurotransmission (51) but make it very unlikely that ICC-DMP could be the origin of nifedipine-sensitive Ca2+ action potentials in W/WV and Sl/Sld mice lacking ICC-MY (see Refs. 17, 18, 49).
We reported previously (3) that ICC-IM of the fundus can generate basic electrical rhythmicity (called unitary potentials), but these events do not regenerate and organize into slow waves. In this study we speculated that ICC-IM may lack the voltage-dependent means of coordinating pacemaker activity, which occurs via voltage-dependent Ca2+ channels. A lack of voltage-dependent Ca2+ channels in ICC-DMP is consistent with the inability of these cells to generate (or organize) electrical rhythmicity in the murine small intestine (50).
Using the new separation technique for ICC-DMP and ICC-MY, we attempted to detect, quantify, and purify these two classes of murine ICC in cell suspensions. FCM analysis indicated that after dead and potentially contaminating cells (macrophages, dendritic cells, mast cells, fibroblasts, and endothelial cells) were excluded Kit+ cells could be separated into Kit+SP and Kit+SP+ populations. Kit+ ICC represented 7.1 ± 1.2% of all cells in suspensions of cells from the tunica muscularis. Consistent with immunohistochemical observations, ICC-DMP represented a considerably smaller fraction of total ICC (21.1 ± 3.9%) than ICC-MY. Although ICC-MY had significantly lower median Kit fluorescence intensities than ICC-DMP, this difference was due to a marked heterogeneity of Kit expression by ICC-MY and the two ICC subsets could not be distinguished by Kit immunofluorescence alone. The relative fractions of ICC classes varied little between experiments (n = 8), indicating that quantitative assessment of ICC populations can be considered a reliable tool for assessing pathological changes in ICC populations in disease models (see Ref. 29 for review), and this might become a diagnostic tool for the assessment of the involvement of ICC in human motility disorders. In addition to FCM analysis, we have also purified ICC-DMP and ICC-MY in large quantities (up to
12,000 and
55,000 per small intestine, respectively) and at high levels of purity necessary and sufficient for large-scale analysis of their gene expression profiles. These results verify our hypothesis that ICC-DMP and ICC-MY of the murine small intestine can be selectively identified and sorted on the basis of receptor-mediated uptake of labeled SP and Kit immunofluorescence. This may help in the development of genetic fingerprints for specific classes of ICC that might be adversely affected in various human motility disorders.
| GRANTS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
2. Bayguinov OP, Hagen BM, Sanders KM. Enteric inhibitory neural signaling via VIP and PACAP is mediated by cAMP-dependent regulation of Ca2+ transients (Abstract). Gastroenterology 128, Suppl 2: A-607, 2005.
3. Beckett EA, Bayguinov YR, Sanders KM, Ward SM, Hirst GD. Properties of unitary potentials generated by intramuscular interstitial cells of Cajal in the murine and guinea-pig gastric fundus. J Physiol 559: 259269, 2004.
4. Beckett EAH, Takeda Y, Yanase H, Sanders KM, Ward SM. Synaptic specializations exist between enteric motor nerves and interstitial cells of Cajal in the murine stomach. J Comp Neurol 493: 193206, 2005.[CrossRef][ISI][Medline]
5. Burnstock G, Lavin S. Interstitial cells of Cajal and purinergic signalling. Auton Neurosci 97: 6872, 2002.[CrossRef][ISI][Medline]
6. De Lorijn F, de Jonge WJ, Wedel T, Vanderwinden JM, Benninga MA, Boeckxstaens GE. Interstitial cells of Cajal are involved in the afferent limb of the rectoanal inhibitory reflex. Gut 54: 11071113, 2005.
7. Epperson A, Hatton WJ, Callaghan B, Doherty P, Walker RL, Sanders KM, Ward SM, Horowitz B. Molecular markers expressed in cultured and freshly isolated interstitial cells of Cajal. Am J Physiol Cell Physiol 279: C529C539, 2000.
8. Forrest AS, Ördög T, Sanders KM. Neural regulation of slow wave frequency in the murine gastric antrum. Am J Physiol Gastrointest Liver Physiol 290: G486G495, 2006.
9. Fox EA, Phillips RJ, Byerly MS, Baronowsky EA, Chi MM, Powley TL. Selective loss of vagal intramuscular mechanoreceptors in mice mutant for steel factor, the c-Kit receptor ligand. Anat Embryol (Berl) 205: 325342, 2002.[CrossRef][Medline]
10. Fox EA, Phillips RJ, Martinson FA, Baronowsky EA, Powley TL. C-Kit mutant mice have a selective loss of vagal intramuscular mechanoreceptors in the forestomach. Anat Embryol (Berl) 204: 1126, 2001.[CrossRef][Medline]
11. Fujita A, Okishio Y, Fujinami K, Nakagawa M, Takeuchi T, Takewaki T, Hata F. Role of the interstitial cells of Cajal distributed in the myenteric plexus in neural reflexes in the mouse ileum. J Pharmacol Sci 96: 483492, 2004.[CrossRef][ISI][Medline]
12. Grider JR. Identification of neurotransmitters regulating intestinal peristaltic reflex in humans. Gastroenterology 97: 14141419, 1989.[ISI][Medline]
13. Hashitani H, Garcia-Londoño AP, Hirst GD, Edwards FR. Atypical slow waves generated in gastric corpus provide dominant pacemaker activity in guinea pig stomach. J Physiol 569: 459465, 2005.
14. Hirst GDS, Dickens EJ, Edwards FR. Pacemaker shift in the gastric antrum of guinea-pigs produced by excitatory vagal stimulation involves intramuscular interstitial cells. J Physiol 541: 917928, 2002.
15. Hirst GDS, Ward SM. Interstitial cells: involvement in rhythmicity and neural control of gut smooth muscle. J Physiol 550: 337346, 2003.
16. Horváth VJ, Vittal H, Lórincz A, Chen H, Almeida-Porada G, Redelman D, Ördög T. Reduced stem cell factor links smooth myopathy and loss of interstitial cells of Cajal in murine diabetic gastroparesis. Gastroenterology 130: 759770, 2006.[CrossRef][ISI][Medline]
17. Huizinga JD. Gastrointestinal peristalsis: joint action of enteric nerves, smooth muscle, and interstitial cells of Cajal. Microsc Res Tech 47: 239247, 1999.[CrossRef][ISI][Medline]
18. Huizinga JD, Thuneberg L, Klüppel M, Malysz J, Mikkelsen HB, Bernstein A. W/kit gene required for intestinal pacemaker activity. Nature 373: 347349, 1995.[CrossRef][Medline]
19. Iino S, Ward SM, Sanders KM. Interstitial cells of Cajal are functionally innervated by excitatory motor neurones in the murine intestine. J Physiol 556: 521530, 2004.
20. Kim YC, Koh SD, Sanders KM. Voltage-dependent inward currents of interstitial cells of Cajal from murine colon and small intestine. J Physiol 541: 797810, 2002.
21. Koesling D. Studying the structure and regulation of soluble guanylyl cyclase. Methods 19: 485493, 1999.[CrossRef][ISI][Medline]
22. Koh SD, Sanders KM, Ward SM. Spontaneous electrical rhythmicity in cultured interstitial cells of Cajal from the murine small intestine. J Physiol 513: 203213, 1998.
23. Koh SD, Ward SM, Ördög T, Sanders KM, Horowitz B. Conductances responsible for slow wave generation and propagation in interstitial cells of Cajal. Curr Opin Pharmacol 3: 579582, 2003.[CrossRef][ISI][Medline]
24. Korman LY, Sayadi H, Bass B, Moody TW, Harmon JW. Distribution of vasoactive intestinal polypeptide and substance P receptors in human colon and small intestine. Dig Dis Sci 34: 11001108, 1989.[CrossRef][ISI][Medline]
25. Lavin ST, Southwell BR, Murphy R, Jenkinson KM, Furness JB. Activation of neurokinin 1 receptors on interstitial cells of Cajal of the guinea-pig small intestine by substance P. Histochem Cell Biol 110: 263271, 1998.[CrossRef][ISI][Medline]
26. Liu L, Shang F, Markus I, Burcher E. Roles of substance P receptors in human colon circular muscle: alterations in diverticular disease. J Pharmacol Exp Ther 302: 627635, 2002.
27. Miller SM, Farrugia G, Schmalz PF, Ermilov LG, Maines MD, Szurszewski JH. Heme oxygenase 2 is present in interstitial cell networks of the mouse small intestine. Gastroenterology 114: 239244, 1998.[CrossRef][ISI][Medline]
28. Ördög T, Redelman D, Horváth VJ, Miller LJ, Horowitz B, Sanders KM. Quantitative analysis by flow cytometry of interstitial cells of Cajal, pacemakers and mediators of neurotransmission in the gastrointestinal tract. Cytometry A 62: 139149, 2004.[CrossRef][Medline]
29. Ördög T, Redelman D, Miller LJ, Horváth VJ, Zhong Q, Almeida-Porada G, Zanjani ED, Horowitz B, Sanders KM. Purification of interstitial cells of Cajal by fluorescence-activated cell sorting. Am J Physiol Cell Physiol 286: C448C456, 2004.
30. Poole DP, Nguyen TV, Kawai M, Furness JB. Protein kinases expressed by interstitial cells of Cajal. Histochem Cell Biol 121: 2130, 2004.[CrossRef][ISI][Medline]
31. Porcher C, Horowitz B, Bayguinov O, Ward SM, Sanders KM. Constitutive expression and function of cyclooxygenase-2 in murine gastric muscles. Gastroenterology 122: 14421454, 2002.[CrossRef][ISI][Medline]
32. Portbury AL, Furness JB, Young HM, Southwell BR, Vigna SR. Localisation of NK1 receptor immunoreactivity to neurons and interstitial cells of the guinea-pig gastrointestinal tract. J Comp Neurol 367: 342351, 1996.[CrossRef][ISI][Medline]
33. Publicover NG, Hammond EM, Sanders KM. Amplification of nitric oxide signaling by interstitial cells isolated from canine colon. Proc Natl Acad Sci USA 90: 20872091, 1993.
34. Sanders KM. A case for interstitial cells of Cajal as pacemakers and mediators of neurotransmission in the gastrointestinal tract. Gastroenterology 111: 492515, 1996.[CrossRef][ISI][Medline]
35. Sanders KM, Ördög T, Koh SD, Torihashi S, Ward SM. Development and plasticity of interstitial cells of Cajal. Neurogastroenterol Motil 11: 311338, 1999.[CrossRef][ISI][Medline]
36. Sanders KM, Ördög T, Koh SD, Ward SM. A novel pacemaker mechanism drives gastrointestinal rhythmicity. News Physiol Sci 15: 291298, 2000.
37. Schultz T, Daniel V, Daniel EE. Does ICC pacing require functional gap junctions between ICC and smooth muscle in mouse intestine? Neurogastroenterol Motil 15: 129138, 2003.[CrossRef][ISI][Medline]
38. Shuttleworth CW, Xue C, Ward SM, de Vente J, Sanders KM. Immunohistochemical localization of 3',5'-cyclic guanosine monophosphate in the canine proximal colon: responses to nitric oxide and electrical stimulation of enteric inhibitory neurons. Neuroscience 56: 513522, 1993.[CrossRef][ISI][Medline]
39. Smith VC, Sagot MA, Couraud JY, Buchan AMJ. Localization of the neurokinin 1 (NK-1) receptor in the human antrum and duodenum. Neurosci Lett 253: 4952, 1998.[CrossRef][ISI][Medline]
40. Southwell BR. Localization of protein kinase C theta immunoreactivity to interstitial cells of Cajal in guinea-pig gastrointestinal tract. Neurogastroenterol Motil 15: 139147, 2003.[CrossRef][ISI][Medline]
41. Sternini C, Wong H, Wu SV, de Giorgio R, Yang M, Reeve J Jr, Brecha NC, Walsh JH. Somatostatin 2A receptor is expressed by enteric neurons, and by interstitial cells of Cajal and enterochromaffin-like cells of the gastrointestinal tract. J Comp Neurol 386: 396408, 1997.[CrossRef][ISI][Medline]
42. Strege P, Ou Y, Rich A, Lei S, Gibbons SJ, Sarr MG, Szurszewski JH, Farrugia G. Sodium current and its effect on the slow wave in human intestinal interstitial cells of Cajal. Am J Physiol Gastrointest Liver Physiol 285: G1111G1121, 2003.
43. Thomsen L, Robinson TL, Lee JC, Farraway LA, Hughes MJ, Andrews DW, Huizinga JD. Interstitial cells of Cajal generate a rhythmic pacemaker current. Nat Med 4: 848851, 1998.[CrossRef][ISI][Medline]
44. Tokutomi N, Maeda H, Tokutomi Y, Sato D, Sugita M, Nishikawa S, Nishikawa SI, Nakao J, Imamura T, Nishi K. Rhythmic Cl current and physiological roles of the intestinal c-kit-positive cells. Pflügers Arch 431: 169177, 1995.[CrossRef][ISI][Medline]
45. Vannucchi MG, Corsani L, Bani D, and Faussone-Pellegrini MS. Myenteric neurons and interstitial cells of Cajal of mouse colon express several nitric oxide synthase isoforms. Neurosci Lett 326: 191195, 2002.[CrossRef][ISI][Medline]
46. Vannucchi MG and Faussone-Pellegrini MS. NK1, NK2 and NK3 tachykinin receptor localization and tachykinin distribution in the ileum of the mouse. Anat Embryol (Berl) 202: 247255, 2000.[CrossRef][Medline]
47. Wang XY, Paterson C, Huizinga JD. Cholinergic and nitrergic innervation of ICC-DMP and ICC-IM in the human small intestine. Neurogastroenterol Motil 15: 531543, 2003.[CrossRef][ISI][Medline]
48. Wang XY, Sanders KM, Ward SM. Intimate relationship between interstitial cells of Cajal and enteric nerves in the guinea-pig small intestine. Cell Tissue Res 295: 247256, 1999.[CrossRef][ISI][Medline]
49. Ward SM, Burns AJ, Torihashi S, Harney SC, Sanders KM. Impaired development of interstitial cells and intestinal electrical rhythmicity in steel mutants. Am J Physiol Cell Physiol 269: C1577C1585, 1995.
50. Ward SM, Burns AJ, Torihashi S, Sanders KM. Mutation of the proto-oncogene c-kit blocks development of interstitial cells and electrical rhythmicity in murine intestine. J Physiol 480: 9197, 1994.[ISI][Medline]
51. Ward SM, McLaren GJ, Sanders KM. Interstitial cells of Cajal in the deep muscular plexus mediate enteric motor neurotransmission in the small intestine. J Physiol 573: 147159, 2006.
52. Ward SM, Ördög T, Koh SD, Abu Baker S, Jun JY, Amberg G, Monaghan K, Sanders KM. Pacemaking in interstitial cells of Cajal depends upon calcium handling by endoplasmic reticulum and mitochondria. J Physiol 525: 355361, 2000.
53. Ward SM, Sanders KM. Interstitial cells of Cajal: primary targets of enteric motor innervation. Anat Rec 262: 125135, 2001.[CrossRef][Medline]
54. Won KJ, Sanders KM, Ward SM. Interstitial cells of Cajal mediate mechanosensitive responses in the stomach. Proc Natl Acad Sci USA 102: 1491314918, 2005.
55. Young HM, McConalogue K, Furness JB, de Vente J. Nitric oxide targets in the guinea-pig intestine identified by induction of cyclic GMP immunoreactivity. Neuroscience 55: 583596, 1993.[CrossRef][ISI][Medline]
56. Zhu Y, Mucci A, Huizinga JD. Inwardly rectifying chloride channel activity in intestinal pacemaker cells. Am J Physiol Gastrointest Liver Physiol 288: G809G821, 2005.
This article has been cited by other articles:
![]() |
B. McDonnell, R. Hamilton, M. Fong, S. M. Ward, and K. D. Keef Functional evidence for purinergic inhibitory neuromuscular transmission in the mouse |